News

SMCP Expands Reach with New Partnerships in Southeast Asia

SMCP Expands Reach with New Partnerships in Southeast Asia

SMCP's Growing Global Footprint

SMCP is excited to share a significant milestone in its international expansion efforts. The luxury fashion group, known for its unique brands such as Sandro, Maje, Claudie Pierlot, and Fursac, is partnering with two major players in the Asia-Pacific region: SSI Group in the Philippines and Map Group in Indonesia.

New Strategic Partnerships

The formation of these distribution partnerships marks a crucial step forward for SMCP, especially following its recent entry into the Indian market. Both Indonesia and the Philippines are vital growth engines within the APAC region, showcasing strong economic performance and a growing middle class, making them prime markets for luxury fashion brands.

In Jakarta, the capital of Indonesia, SMCP has proudly launched its first Sandro store at Plaza Senayan. But the company's ambitions don't stop there; it plans to open four more stores in the vibrant shopping areas of Greenbelt and Central Square in metropolitan Manila, along with three dedicated corners in Rustan's Makati department stores. Over the next five years, SMCP aims to further enhance its presence in these markets, targeting prestigious shopping malls and upscale locations.

Map Group's Impact in Indonesia

Map Group has a rich history in Indonesia, having successfully operated in the market since 1995. As a key distributor, it has made a name for itself across various sectors, including fashion, cosmetics, and sports. Currently, Map Group manages nearly 3,000 shops in about 80 cities across Indonesia, collaborating with well-known brands like the Inditex Group, Loewe, Max Mara, Lacoste, and Starbucks. This extensive network makes Map Group an ideal partner for SMCP as it seeks to enter the Indonesian luxury market.

SSI Group's Role in the Philippines

Based in the Philippines, SSI Group specializes in luxury fashion and ready-to-wear retail. With around 570 stores nationwide representing 90 different brands, SSI's collaborations with prestigious fashion houses such as Cartier, Hermès, and Givenchy enhance its standing in the luxury sector. This strategic partnership aims to strengthen SMCP's presence in the Filipino market, further solidifying its position in Southeast Asia.

SMCP: A Leader in Accessible Luxury

SMCP has established itself as a prominent player in the accessible luxury market. With its four distinct Parisian brands, each offering a unique aesthetic, the company has made its mark in 46 countries. With over 1,600 stores globally and a strong digital presence, SMCP is not just a retailer; it is a significant influencer in the global fashion landscape.

Contact Information for Inquiries

For inquiries from investors and the press, SMCP has established dedicated contact points to facilitate communication. Amélie Dernis represents SMCP, while the Brunswick Group, led by Hugues Boëton and Tristan Roquet Montegon, is available for broader investor relations. They encourage inquiries through the official contact numbers and email addresses provided for each representative.

Frequently Asked Questions

What new markets is SMCP entering?

SMCP is expanding its reach into Indonesia and the Philippines through new distribution partnerships.

Who are SMCP's local partners in Asia?

The company has partnered with SSI Group in the Philippines and Map Group in Indonesia.

How many stores does SMCP plan to open in the Philippines?

SMCP intends to open four stores in key districts of metropolitan Manila, along with additional corners in high-end department stores.

What brands are included under SMCP?

SMCP encompasses luxury fashion brands such as Sandro, Maje, Claudie Pierlot, and Fursac.

Where can I find more information about SMCP?

For further inquiries, you can reach out to their investor and press representatives using the contact details provided.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Container Store Group Faces Delisting by NYSE Amid Market Challenges

Updated Category News Views 145

Container Store Group's NYSE Delisting Announcement The New York Stock Exchange (NYSE) has made a significant announcement regarding the trading status of The Container Store Group, Inc. (TCS). The Exchange's staff has determined that it will initiate proceedings to delist the Company's common stock. This decision comes in light of the Company's recent performance in the...

Continue Reading
Investing in Vanguard Russell 2000 ETF: A Strategic Approach

Updated Category News Views 200

Investing in the Vanguard Russell 2000 ETF: A Strategic Approach In recent years, the stock market's performance has been largely driven by large corporations. While megacap tech stocks have thrived, small-cap stocks have struggled to keep pace. This has resulted in significant valuation discounts for smaller companies compared to their larger peers. Over the past five...

Continue Reading
Welcoming Ann Dunkin to Our Esteemed Board of Directors

Updated Category News Views 156

Ann Dunkin Joins Our Board of Directors We are thrilled to announce the appointment of Ann Dunkin, P.E., to our Board of Directors. With an extensive background in engineering and a strong commitment to public service, Ann's diverse expertise will be invaluable as we navigate the challenges and opportunities in our industry. Professional Background of Ann Dunkin Ann...

Continue Reading
Management Trading Insights on Unexpected Developments

Updated Category News Views 150

Understanding Management Trading Activities When assessing a company's health and future prospects, observing management trading can provide invaluable insights. Executive transactions—buying or selling shares—often reflect their confidence in the business's performance. An increase in stock purchases by management usually signals optimism, while significant sales may...

Continue Reading
Tovecimig's Efficacy in Biliary Tract Cancer Study Unveiled

Updated Category News Views 254

Breakthrough Findings in Biliary Tract Cancer Treatment Compass Therapeutics, Inc. has announced promising interim results from their ongoing Phase 2/3 study, COMPANION-002, examining the efficacy of tovecimig, formerly known as CTX-009, in combination with paclitaxel for treating advanced biliary tract cancer (BTC). Tovecimig, a bispecific antibody targeting both DLL4...

Continue Reading